LENZ Therapeutics (LENZ) Current Leases (2021 - 2023)
LENZ Therapeutics (LENZ) posted quarterly Current Leases of $285000.0 for Q4 2023, down 92.95% year-over-year from $4.0 million in Q4 2022, and down 91.71% quarter-over-quarter from $3.4 million in Q3 2023.
LENZ Therapeutics (LENZ) Current Leases (2021 - 2023) Analysis & Trends
LENZ Therapeutics (LENZ) has reported Current Leases for 3 consecutive years, with $285000.0 the latest figure, recorded in Q4 2023.
- In Q4 2023, Current Leases fell 92.95% year-over-year to $285000.0; the TTM figure through Dec 2023 stood at $285000.0 (down 92.95% YoY), while the FY2023 annual figure was $285000.0, down 92.95% from the prior year.
- Current Leases declined to $285000.0 in Q4 2023 per LENZ's latest filing, from $3.4 million in the prior quarter.
- Across five years, Current Leases topped out at $5.6 million in Q1 2022 and bottomed at $285000.0 in Q4 2023.
- Historically, Current Leases has averaged $3.9 million across 3 years, with a median of $4.3 million in 2022.
- Annual changes were most pronounced in 2022 — Current Leases slipped 4.29% — and 2023, when it sank 92.95%.
- LENZ Therapeutics' Current Leases stood at $5.5 million in 2021, then declined by 26.21% to $4.0 million in 2022, then tumbled by 92.95% to $285000.0 in 2023.
- Business Quant data shows LENZ's Current Leases at $285000.0 in Q4 2023, $3.4 million in Q3 2023, and $2.9 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | LENZ Therapeutics | 148.40 Mn | 148.40 Mn | 5.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 285,000.00 |
| Sep 30, 2023 | 3.44 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 3.10 Mn |
| Dec 31, 2022 | 4.05 Mn |
| Sep 30, 2022 | 4.60 Mn |
| Jun 30, 2022 | 4.90 Mn |
| Mar 31, 2022 | 5.64 Mn |
| Dec 31, 2021 | 5.48 Mn |
| Sep 30, 2021 | 4.81 Mn |